Richard J. Berman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Princeton, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kyle Fletcher, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard J. Berman

Form 4 holding Director

Cryoport, Inc.

Security class
Common Stock
Shares / value
112,845
Estimated value
$1,513,319
Report date
17 May 2024
Price
$13.41
Ownership
Direct
Form 4 holding Director

Celularity Inc

Security class
Class A Common Stock
Shares / value
67,416
Estimated value
$277,080
Report date
19 Dec 2024
Price
$4.11
Ownership
Direct
Form 4 holding Director

BIOVIE INC.

Security class
Common Stock
Shares / value
40,643
Estimated value
$19,265
Report date
20 Nov 2024
Price
$0.4740
Ownership
Direct
Form 4 holding Director

Celularity Inc

Security class
Stock Option (Right to Buy)
Shares / value
202,857
Estimated value
Report date
19 Dec 2024
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

Celularity Inc

Security class
Stock Option Grant (Right to Buy)
Shares / value
118,111
Estimated value
Report date
27 Aug 2024
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

Context Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
50,000
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Frontier Investment Corp

Security class
Ordinary Shares, $0.0001 par value
Shares / value
31,250
Estimated value
Report date
30 Jun 2021
Price
Ownership
Indirect economic interest for the value of the identified amount of shares.
Form 4 holding Director

Cryoport, Inc.

Security class
Option (Right to Buy Common Stock)
Shares / value
23,830
Estimated value
Report date
17 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

BIOVIE INC.

Security class
Stock Option (right to buy)
Shares / value
23,155
Estimated value
Report date
20 Dec 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Richard J. Berman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .